Cemiplimab

Definition: Cemiplimab, sold under the brand name Libtayo, is a monoclonal antibody medication for the treatment of squamous cell skin cancer. Cemiplimab belongs to a class of drugs that binds to the programmed death receptor-1 (PD-1), blocking the PD-1/PD-L1 pathway. The most common side effects include fatigue, rash, diarrhea, musculoskeletal pain, and nausea. source: Wikipedia

ID

781555007

ID date

7 Jan 2022

Previous ID

37334011000001103

Name

Cemiplimab